Schizophrenia and oxidative stress: glutamate cysteine ligase modifier as a susceptibility gene.
case_control · Level III
Where this comes from
- Record sourced from PubMed, PMID 16909399.
- Also identified by PMC identifier 1559555.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Oxidative stress could be involved in the pathophysiology of schizophrenia, a major psychiatric disorder. Glutathione (GSH), a redox regulator, is decreased in patients' cerebrospinal fluid and prefrontal cortex. The gene of the key GSH-synthesizing enzyme, glutamate cysteine ligase modifier (GCLM) subunit, is strongly associated with schizophrenia in two case-control studies and in one family study. GCLM gene expression is decreased in patients' fibroblasts. Thus, GSH metabolism dysfunction is proposed as one of the vulnerability factors for schizophrenia.
Medical subject headings
- Genetic Predisposition to Disease
- Glutamate-Cysteine Ligase
- Oxidative Stress
- Schizophrenia